Last Updated on 07/14/2026
Follow KBKG on Social Media
Foreign-owned companies operating in the United States often ask whether they can claim the U.S. federal Research and Development Tax Credit. In many cases, the answer is yes. U.S. tax rules do not automatically prevent a business from claiming the R&D credit simply because the company has foreign ownership.
Eligibility generally depends on where the research is performed, whether the activities satisfy the applicable IRS requirements, and whether the taxpayer has a U.S. filing position that allows it to claim the credit. Current IRS guidance focuses on domestic qualified research, economic risk, and substantial rights in the research results. Foreign ownership can add complexity, but it does not, by itself, disqualify a company from claiming the credit.
Eligibility Depends on U.S.-Based Activities
For a foreign-owned company to claim the U.S. R&D Tax Credit, the qualified research must be performed in the United States or a U.S. territory. The location of the parent company is not the determining factor. What matters is whether the U.S. entity is conducting qualifying research domestically.
KBKG’s Cross-Border R&D Qualification Framework starts with one core distinction: foreign ownership is not the disqualifying factor; the location, funding, and documentation of the research are. According to the R&D experts at KBKG, the key question is whether the U.S. taxpayer performed domestic qualified research, bore the appropriate economic risk, retained substantial rights, and can substantiate the qualified research expenses tied to those activities.
A U.S. subsidiary or affiliate may be eligible if its activities meet the four-part test for qualified research. In some cases, a foreign corporation operating directly in the United States may also need to evaluate whether it has sufficient U.S. nexus to support a filing position for the credit.
The Four-Part Test is as follows:
- Permitted Purpose: Activities must be performed in an attempt to improve the functionality, performance, reliability, or quality of a new or existing business component.
- Technological Uncertainty: Activities intended to discover information that could eliminate technical uncertainty concerning the development or improvement of a product.
- Process of Experimentation: All of the activities must include a process of experimentation including testing, modeling, simulating, systematic trial and error.
- Technological in Nature: Activities must fundamentally rely on the principles of physical or biological science, engineering, or computer science.
If the U.S.-based operations meet these standards, where the parent company is owned and located is irrelevant when it comes to federal R&D credit eligibility.
Key Complexities to Address
While eligibility is possible, foreign-owned businesses must navigate some unique challenges when it comes to compliance and structuring. KBKG has listed out some of the most common challenges below:
- Only U.S.-Based Research Expenses Qualify:
One of the biggest limitations for foreign-owned entities is that only R&D performed physically within the United States qualifies for the credit. If your teams abroad, such as in Europe or Asia, are performing the bulk of the research, those expenses will not be eligible, even if the work is later implemented or commercialized in the U.S.
It’s important to carefully segregate U.S.-based wages, supply costs, and contractor expenses from those incurred overseas to ensure proper credit calculation and avoid disallowed claims. - Funded Research Rules Can Affect Eligibility:
If a foreign parent or related party funds the U.S. subsidiary’s research, the company must evaluate whether the funded research exclusion applies based on the controlled group rules. A U.S. entity may be unable to claim the credit if it does not meet all the proper rules related to controlled groups and funding.
Clear contracts, intellectual property provisions, and risk-allocation terms are important when related parties are involved.
- Documentation & Substantiation Are Critical:
Foreign-owned companies should maintain strong contemporaneous documentation to support an R&D credit claim. In KBKG’s R&D experts’ experience, documentation is often the difference between a supportable credit position and a claim that becomes difficult to defend, especially when U.S. and foreign research teams are working on related projects.
Foreign-owned companies should organize their R&D credit documentation around the projects, people, places, and payments tied to the claim: what technical uncertainty was addressed, who performed the work, where the research occurred, and how wages, supplies, and contractor costs were separated between U.S. and non-U.S. activities.
- Controlled Group Rules May Apply:
Foreign-owned corporations with multiple U.S. subsidiaries must evaluate whether they are part of a controlled group of corporations. Under IRS rules, such groups are required to aggregate their qualified research expenditures when computing the R&D credit.This has implications for how the credit is calculated and allocated. Companies need to assess ownership thresholds, control structures, and coordination across related U.S. entities to comply with aggregation rules.
- Treaty and Nexus Issues May Affect How the Credit Is Claimed:
Tax treaties can affect whether a foreign corporation is subject to U.S. income tax, but they do not expand the definition of qualified research under the federal R&D credit rules. Current IRS guidance still requires that qualified research be performed in the United States and that the taxpayer otherwise satisfy the section 41 requirements.
Foreign-owned companies should also review whether the entity claiming the credit has the necessary U.S. tax nexus and filing obligations. A foreign parent with no U.S. tax return filing position generally cannot claim the credit directly, while a U.S. subsidiary or other U.S. taxpayer may be able to claim it if the qualified research expenses are properly incurred and documented.
- Tax Treaty Provisions Do Not Override Core Qualification Rules:
U.S. income tax treaties can affect whether a foreign enterprise is treated as having a taxable presence in the United States, often through permanent establishment standards. However, treaty provisions do not expand the definition of qualified research or qualified research expenses for federal R&D credit purposes.
If a treaty limits the foreign enterprise’s U.S. taxable presence, that may affect whether the enterprise can currently use a credit on a U.S. return. The underlying qualification rules still focus on U.S.-performed research, qualified expenses, financial risk, and substantial rights.
Conclusion
Foreign-owned businesses with U.S. operations may be able to and often benefit from the U.S. federal R&D Tax Credit when qualifying research is performed in the United States. The key is to focus on domestic research activities, maintain reliable documentation, confirm that the proper U.S. taxpayer is claiming the credit, and address the special issues that arise in multinational structures.
With proper planning, foreign-owned companies can use the R&D credit to reduce U.S. tax liability, support continued innovation, and remain aligned with IRS requirements.
KBKG’s Cross-Border R&D Credit Review helps foreign-owned companies evaluate the issues that matter most: where the research was performed, which entity incurred the qualified expenses, whether funded research or substantial rights rules apply, and whether the documentation supports the credit.
Businesses with complex ownership structures, U.S. subsidiaries, or cross-border research arrangements can request a free consultation with KBKG’s R&D tax credit experts to evaluate eligibility and identify the documentation needed to support a claim.
Frequently Asked Questions
Can a foreign parent company claim the U.S. R&D tax credit directly?
It depends on whether the foreign parent has a U.S. return filing position and directly incurs qualified research expenses in the United States. In many cases, the claim is made by the U.S. subsidiary or other U.S. entity that performed the research and bore the cost.
Do research activities performed outside the United States qualify for the credit?
Generally, no. The federal R&D credit is limited to qualifying research performed in the United States or a U.S. territory, so foreign research costs are typically excluded from the calculation.
Can a tax treaty allow a company to bypass the funded research or substantial rights rules?
No. A tax treaty may affect whether a foreign enterprise has a U.S. taxable presence, but it does not override the core R&D credit requirements. Companies still need to analyze funding arrangements, financial risk, and rights to the research results under the normal federal credit rules.